10 must-read Q&As on biologics from 2018

Here are 10 must-read Q&As from 2018 on biologics.

Advertisement

1. Dr. James Bicos: Why biologics is so exciting for the future of orthopedics

2. Dr. Alpesh Patel: The biggest challenge in spine today + new innovations in spinal biologics

3. ‘A new dawn’ for orthopedics: Dr. Jason Arora on the promise of biologics

4. Biologics in spine surgery holds great promise — Dr. Choll Kim shares insight into new field

5. The best opportunities for spinal biologics & practice improvement today: Q&A with Dr. Jeffrey Wang

6. We’ve entered the ‘Anabolic Era of Orthopedics’: Dr. Kevin Stone talks biologic solutions

7. Spinal biologics — Will evidence support it? Key thoughts from Drs. D. Greg Anderson, Scott Blumenthal & William Tally

8. Watch out for spinal biologics in 2018 — 2 key thoughts from Dr. Roger Hartl

9. Hope springs eternal — Dr. Michael Gordon on the use of biologics in the coming years

10. Major breakthroughs in spinal biologics, disc regeneration on the horizon: 3 key thoughts from Dr. William Watters

More articles on biologics:
Drs. Christopher Kaeding, David Flanigan perform 1st case with CartiHeal implant: 4 things to know
Biorez opens new offices in Connecticut: 3 things to know
Dr. James Bicos: Why biologics is so exciting for the future of orthopedics

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.